These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23141855)

  • 1. Age-related maximum heart rate among ischemic and nonischemic heart failure patients receiving β-blockade therapy.
    Fernandes Silva MM; Bacal F; Roque JM; Teixeira-Neto IS; Carvas Junior N; Bocchi EA; Guimarães GV
    J Card Fail; 2012 Nov; 18(11):831-6. PubMed ID: 23141855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting maximum heart rate among patients with coronary heart disease receiving beta-adrenergic blockade therapy.
    Brawner CA; Ehrman JK; Schairer JR; Cao JJ; Keteyian SJ
    Am Heart J; 2004 Nov; 148(5):910-4. PubMed ID: 15523326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age on aerobic capacity in heart failure patients under beta-blocker therapy: possible impact in clinical decision-making?
    Ciolac EG; Bocchi EA; Fernandes da Silva MM; Tavares AC; Teixeira-Neto IS; Guimarães GV
    Cardiol J; 2013; 20(6):655-61. PubMed ID: 24338544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with β-blocker therapy.
    Guimaraes GV; d'Avila VM; Silva MS; Ferreira SA; Ciolac EG; Carvalho VO; Bocchi EA
    Int J Cardiol; 2010 Nov; 145(1):75-7. PubMed ID: 19477026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
    Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
    Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study.
    Dekleva M; Düngen HD; Gelbrich G; Incrot S; Suzic Lazic J; Pavlovic Kleut M; Tahirovic E; Waagstein F
    Aging Clin Exp Res; 2012 Dec; 24(6):675-81. PubMed ID: 23147689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy.
    Sheppard RJ; Racine N; Roof A; Ducharme A; Blanchet M; White M
    Can J Cardiol; 2007 Dec; 23(14):1135-8. PubMed ID: 18060099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate dynamics in heart transplantation patients during a treadmill cardiopulmonary exercise test: a pilot study.
    Carvalho VO; Pascoalino LN; Bocchi EA; Ferreira SA; Guimarães GV
    Cardiol J; 2009; 16(3):254-8. PubMed ID: 19437401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
    Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.
    de Groote P; Delour P; Mouquet F; Lamblin N; Dagorn J; Hennebert O; Le Tourneau T; Foucher-Hossein C; Verkindère C; Bauters C
    Am Heart J; 2007 Sep; 154(3):589-95. PubMed ID: 17719311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.
    Shore S; Aggarwal V; Zolty R
    J Card Fail; 2012 Dec; 18(12):919-24. PubMed ID: 23207080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
    Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
    J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting maximal HR in heart failure patients on β-blockade therapy.
    Keteyian SJ; Kitzman D; Zannad F; Landzberg J; Arnold JM; Brubaker P; Brawner CA; Bensimhon D; Hellkamp AS; Ewald G
    Med Sci Sports Exerc; 2012 Mar; 44(3):371-6. PubMed ID: 21900844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
    J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes.
    Takahama H; Yokoyama H; Kada A; Sekiguchi K; Fujino M; Funada A; Amaki M; Hasegawa T; Asakura M; Kanzaki H; Anzai T; Kitakaze M
    J Cardiol; 2013 Jan; 61(1):58-64. PubMed ID: 23165149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired heart rate responses and exercise capacity in heart failure patients with paced baseline rhythms.
    Ujeyl A; Stevenson LW; West EK; Kato M; Liszkowski M; Campbell P; Forman DE
    J Card Fail; 2011 Mar; 17(3):188-95. PubMed ID: 21362525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era.
    La Rovere MT; Pinna GD; Maestri R; Robbi E; Caporotondi A; Guazzotti G; Sleight P; Febo O
    J Am Coll Cardiol; 2009 Jan; 53(2):193-9. PubMed ID: 19130988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology.
    Soliman OI; Theuns DA; ten Cate FJ; Anwar AM; Nemes A; Vletter WB; Jordaens LJ; Geleijnse ML
    Am J Cardiol; 2007 Aug; 100(3):464-9. PubMed ID: 17659930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of atropine in patients with chronotropic incompetence and poor exercise capacity during treadmill stress testing.
    Munagala VK; Guduguntla V; Kasravi B; Cummings G; Gardin JM
    Am Heart J; 2003 Jun; 145(6):1046-50. PubMed ID: 12796761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.